SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-21-000007
Filing Date
2021-06-14
Accepted
2021-06-14 16:58:46
Documents
46
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 vsbc10qapril2021.htm 10-Q 294488
2 ex311.htm EX-31.1 20461
3 ex312.htm EX-31.2 20456
4 ex321.htm EX-32.1 6746
5 ex322.htm EX-32.2 6741
  Complete submission text file 0001697884-21-000007.txt   1465369

Data Files

Seq Description Document Type Size
6 none-20210430.xml EX-101.INS 230776
7 none-20210430.xsd EX-101.SCH 17682
8 none-20210430_cal.xml EX-101.CAL 4576
9 none-20210430_def.xml EX-101.DEF 15669
10 none-20210430_lab.xml EX-101.LAB 147956
11 none-20210430_pre.xml EX-101.PRE 82108
Mailing Address 2372 MORSE AVE. #950 IRVINE CA 92614
Business Address 2372 MORSE AVE. #950 IRVINE CA 92614 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 211015273
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services